EpiTherapeutics is a startup, most recent round Series-c-plus.
EpiTherapeutics is a startup. Its most recent tracked round is Series-c-plus.
EpiTherapeutics is a biotechnology company listed in M Ventures' portfolio under the healthcare and life science categories; M Ventures indicates the company is associated with an IPO.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.